CME
Life-Threatening Bleeding in the Anticoagulated Patient: Real World Evidence
Host: Natalie Kreitzer, MD, MS Patients presenting to the hospital with severe bleeding and underlying treatment with Factor Xa (FXa) or Factor IIa inhibitors represent an enormous challenge to providers and clinicians since the approvals of api